Skip to content
lifestyle.californiaconsumerbanking.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
electroCore, Inc.
electroCore, Inc. Submits 510(k) Premarket Notification to FDA Seeking Clearance of Quell® for the Treatment of Chronic Chemotherapy-Induced Peripheral Neuropathy (CIPN)
October 28, 2026
fMRI Study Suggests Transcutaneous Cervical Vagus Nerve Stimulation (tcVNS) Accelerates Neural Processes in Visual Skill Learning
October 27, 2026
electroCore to Present at Planet MicroCap Toronto 2026 powered by MicroCapClub
October 21, 2026
electroCore to Participate at H.C. Wainwright Global Investment Conference
September 10, 2026
electroCore, Inc. Appoints Joshua Lev and Mike Fox as Co-Chief Executive Officers
September 9, 2026
electroCore’s Truvaga® Named Best Luxury Biohacking & Longevity Brand in the USA by Luxury Lifestyle Awards
August 25, 2026
electroCore Announces Second Quarter 2026 Financial Results
August 6, 2026
electroCore to Participate in Upcoming Investor Conferences
August 3, 2026
electroCore to Announce Second Quarter June 30, 2026, Financial Results on Thursday, August 6, 2026
July 30, 2026
New Review Examines Anatomical and Methodological Differences Between Auricular and Cervical Vagus Nerve Stimulation
July 16, 2026
1
2
Next Page
→